Ordenar

Buscar

01/06/2026 Lower limb compression therapy for tissue decongestion in acute heart failure: design of a multicentre randomised clinical trial
Chover-Sierra, E, Silvestre, JP, Escriva, DG, Villota, JN, Juan, RD, Gomez, JC, Iborra, PL, Pison, EP, Alvarez, MP, Marcos, MC, Azor, JCL, Lopez, AM, Perez, FJP, Simon-Ramon, C, Abello, AV. Lower limb compression therapy for tissue decongestion in acute heart failure: design of a multicentre randomised clinical trial. EUROPEAN JOURNAL OF HEART FAILURE. 2026; 28DOI:10.1093/ejhf/xuag193.721. PMID:. IF:10.800(Q1/1D).
01/06/2026 Real-world one-year effectiveness and safety of vericiguat in patients with heart failure in Spain: results from the multicenter prospective VERISEC study
Fernandez, AE, Bernal, BC, Lopez-Vilella, R, De Lara, G, Belarte-Tornero, L, Barrantes-Castillo, M, Gomez-Otero, I, Nunez-Villlota, J, Gamboa, CR, Lopez-Aguilera, J, Torremocha-Lopez, A, Melendo-Viu, M, Simon-Ramon, C, Burgues, PF, Recio-Mayoral, A. Real-world one-year effectiveness and safety of vericiguat in patients with heart failure in Spain: results from the multicenter prospective VERISEC study. EUROPEAN JOURNAL OF HEART FAILURE. 2026; 28DOI:10.1093/ejhf/xuag193.832. PMID:. IF:10.800(Q1/1D).
01/06/2026 Unveiling discrepancies in heart failure diagnosis among diabetic patients: insights from hospital and primary care data
Munoz, M, Rojo-Lopez, MI, Navas, E, Lopez, M, Franch, J, Cendros, V, Anton, J, Verdu-Rotellar, JM. Unveiling discrepancies in heart failure diagnosis among diabetic patients: insights from hospital and primary care data. EUROPEAN JOURNAL OF HEART FAILURE. 2026; 28DOI:10.1093/ejhf/xuag193.213. PMID:. IF:10.800(Q1/1D).
01/06/2026 Margin evaluation with fluorescence confocal microscopy during minimally invasive radical prostatectomy
Gaya, JM, Verri, P, Gallioli, A, Uleri, A, Basile, G, Afferi, L, Diana, P, Baboudjian, M, Territo, A, Sanguedolce, F, Huguet, J, Arce, Y, Algaba, F, Palou, J, Breda, A. Margin evaluation with fluorescence confocal microscopy during minimally invasive radical prostatectomy. BJU INTERNATIONAL. 2026; 138DOI:10.1111/bju.70264. PMID:41915450. IF:4.400(Q1/2D).
01/06/2026 Body Fluid Cell Differentiation: A Comparison Between CellaVision DI-60 and Manual Microscopy in Pleural and Ascitic Fluids
San-José, P, Aljarilla, A, Jiménez, A, González, N, Hernando-Redondo, J, Nomdedéu-Guinot, JF. Body Fluid Cell Differentiation: A Comparison Between CellaVision DI-60 and Manual Microscopy in Pleural and Ascitic Fluids. International Journal of Laboratory Hematology. 2026; 48DOI:. PMID:. IF:2.300(Q2/5D).
01/06/2026 Minor salivary gland tumours: a 30-year institutional experience
León, X, Vilaró, LL, Szafranska, J, Bagué, S, Maso, A, Valero, C, Holgado, A, Olmo, AP. Minor salivary gland tumours: a 30-year institutional experience. JOURNAL OF LARYNGOLOGY AND OTOLOGY. 2026; 140(6)DOI:10.1017/S0022215126104915. PMID:42093629. IF:0.800(Q3/8D).
30/05/2026 Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study
Povala, G, Bellaver, B, Lussier, FZ, Amaral, L, Bauer-Negrini, G, Ferreira, PCL, Rocha, A, Ruppert, E, Medeiros, MS, Tissot, C, Jagust, WJ, Masdeu, JC, Fortea, J, Tudorascu, DL, Soleimani-Meigooni, DN, Lowe, V, Oh, H, Pascual, B, Gordon, BA, Rosa-Neto, P, Baker, S, Pascoal, TA. Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study. LANCET. 2026; 407(10544)DOI:. PMID:42208563. IF:88.500(Q1/1D).
29/05/2026 Adverse HDL remodelling links type 2 diabetes mellitus to subclinical high-risk coronary plaque burden
Giron, GO, Padró, T, Guala, A, Fernández, R, Garcia-Elias, A, Alcover, S, Ramos-Regalado, L, Otero, S, Borrell-Pagés, M, Oliveró, R, Grieve, SM, Maceira, A, Rodríguez-Palomares, JF, Vilahur, G. Adverse HDL remodelling links type 2 diabetes mellitus to subclinical high-risk coronary plaque burden. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56DOI:. PMID:. IF:3.600(Q1/2D).